Synthetic vaccine peptide epitomes of hepatitis B surface antigen
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 1983
Grant Date -
N/A
app pub date -
Jan 14, 1980
filing date -
Jan 14, 1980
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel oligopeptides are provided having serologic activity for the a determinant of hepatitis B virus surface antigen. Included in the oligopeptide chain are a sequence of at least two cysteines and a lysine in proximity to the cysteines. The oligopeptides can find use in immunoassays, the formulation of vaccines, and the production of antisera.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully